{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:31:32Z","timestamp":1785540692530,"version":"3.56.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T00:00:00Z","timestamp":1696809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T00:00:00Z","timestamp":1696809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The safety and efficacy of 17-gauge needles used in CT-guided percutaneous cryoablation for lung nodules were explored in this study. The purpose of the study was to compare the findings with earlier research and multi-center clinical trials that used various needle sizes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Between 2016 and 2020, a retrospective study was conducted with approval from the institutional review board. A total of 41 patients were enrolled, and 71 lung nodules were treated in 63 cryoablation procedures using local anesthesia. Complication rates were recorded, and overall survival rates as well as tumor progression-free rates were calculated using the Kaplan-Meier method.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Self-limited hemoptysis was caused by 12.9% of the procedures, and drainage was required for pneumothoraces resulting from 11.3% of them. The overall survival rates at one, two, three, and four years were 97%, 94%, 82%, and 67%, respectively. The tumor progression-free rates at one, two, three, and four years were 86.2%, 77%, 74%, and 65%, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Cryoablation for lung nodules using 17-Gauge needles can achieve similar rates of survival and tumor control rates, similar or even lower complication rates as compared with other studies and multi-center trials using mixed sized needles.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12880-023-01110-6","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T11:03:07Z","timestamp":1696849387000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The safety and response of CT guided percutaneous cryoablation for lung nodules by 17-gauge needles"],"prefix":"10.1186","volume":"23","author":[{"given":"Wei-Chan","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Ju","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly","family":"Yim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsueh-Han","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pen-An","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Yu","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hong","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,9]]},"reference":[{"key":"1110_CR1","unstructured":"NCCN Guidelines Insights: Non\u2013Small Cell Lung Cancer, Version 1.2020 in: Journal of the National Comprehensive Cancer Network Volume\u00a017 Issue 12. (2019). Accessed 31 July 2021. https:\/\/jnccn.org\/view\/journals\/jnccn\/17\/12\/article-p1464.xml."},{"issue":"5","key":"1110_CR2","doi-asserted-by":"publisher","first-page":"e246","DOI":"10.1016\/j.ejrad.2012.12.010","volume":"82","author":"C Pusceddu","year":"2013","unstructured":"Pusceddu C, Sotgia B, Fele RM, et al. CT-guided thin needles percutaneous cryoablation (PCA) in patients with primary and secondary lung tumors: a preliminary experience. Eur J Radiol. 2013;82(5):e246\u201353. https:\/\/doi.org\/10.1016\/j.ejrad.2012.12.010.","journal-title":"Eur J Radiol"},{"issue":"8","key":"1110_CR3","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","volume":"27","author":"E Van Cutsem","year":"2016","unstructured":"Van Cutsem E, Cervantes A, Adam R, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27(8):1386\u2013422. https:\/\/doi.org\/10.1093\/annonc\/mdw235.","journal-title":"Ann Oncol"},{"issue":"10","key":"1110_CR4","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1136\/gut.2010.211557","volume":"59","author":"E Mitry","year":"2010","unstructured":"Mitry E, Guiu B, Cosconea S, et al. Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study. Gut. 2010;59(10):1383\u20138. https:\/\/doi.org\/10.1136\/gut.2010.211557.","journal-title":"Gut"},{"issue":"7","key":"1110_CR5","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1200\/JCO.1996.14.7.2047","volume":"14","author":"P Girard","year":"1996","unstructured":"Girard P, Ducreux M, Baldeyrou P, et al. Surgery for lung metastases from colorectal cancer: analysis of prognostic factors. J Clin Oncol. 1996;14(7):2047\u201353. https:\/\/doi.org\/10.1200\/JCO.1996.14.7.2047.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1110_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/jso.21596","volume":"102","author":"JT Kaifi","year":"2010","unstructured":"Kaifi JT, Gusani NJ, Deshaies I, et al. Indications and approach to surgical resection of lung metastases. J Surg Oncol. 2010;102(2):187\u201395. https:\/\/doi.org\/10.1002\/jso.21596.","journal-title":"J Surg Oncol"},{"key":"1110_CR7","unstructured":"Jamil A, Kasi A. Lung Metastasis. In: StatPearls. StatPearls Publishing; 2021. Accessed October 18, 2021. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK553111\/."},{"issue":"11","key":"1110_CR8","doi-asserted-by":"publisher","first-page":"4512","DOI":"10.21037\/jtd.2017.10.108","volume":"9","author":"J Hoerner-Rieber","year":"2017","unstructured":"Hoerner-Rieber J, Duma M, Blanck O, et al. Stereotactic body radiotherapy (SBRT) for pulmonary metastases from renal cell carcinoma\u2014a multicenter analysis of the german working group Stereotactic Radiotherapy. J Thorac Dis. 2017;9(11):4512\u201322. https:\/\/doi.org\/10.21037\/jtd.2017.10.108.","journal-title":"J Thorac Dis"},{"key":"1110_CR9","doi-asserted-by":"publisher","first-page":"e9132359","DOI":"10.1155\/2018\/9132359","volume":"2018","author":"AD Lindsay","year":"2018","unstructured":"Lindsay AD, Haupt EE, Chan CM, et al. Treatment of Sarcoma Lung Metastases with stereotactic body Radiotherapy. Sarcoma. 2018;2018:e9132359. https:\/\/doi.org\/10.1155\/2018\/9132359.","journal-title":"Sarcoma"},{"issue":"6","key":"1110_CR10","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.clgc.2017.04.007","volume":"15","author":"S Shah","year":"2017","unstructured":"Shah S, Zhang CA, Hancock S, et al. Consolidative Radiotherapy in Metastatic Urothelial Cancer. Clin Genitourin Cancer. 2017;15(6):685\u20138. https:\/\/doi.org\/10.1016\/j.clgc.2017.04.007.","journal-title":"Clin Genitourin Cancer"},{"issue":"1","key":"1110_CR11","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1148\/radiol.14132958","volume":"273","author":"M Ahmed","year":"2014","unstructured":"Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting Criteria\u2014A 10-Year update. Radiology. 2014;273(1):241\u201360. https:\/\/doi.org\/10.1148\/radiol.14132958.","journal-title":"Radiology"},{"issue":"6","key":"1110_CR12","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.jvir.2012.02.013","volume":"23","author":"HJ Bang","year":"2012","unstructured":"Bang HJ, Littrup PJ, Currier BP, et al. Percutaneous cryoablation of metastatic lesions from non\u2013small-cell lung carcinoma: initial survival, local control, and cost observations. J Vasc Interv Radiol. 2012;23(6):761\u20139. https:\/\/doi.org\/10.1016\/j.jvir.2012.02.013.","journal-title":"J Vasc Interv Radiol"},{"issue":"5","key":"1110_CR13","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1093\/annonc\/mdv037","volume":"26","author":"T de Ba\u00e8re","year":"2015","unstructured":"de Ba\u00e8re T, Aup\u00e9rin A, Deschamps F, et al. Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases. Ann Oncol. 2015;26(5):987\u201391. https:\/\/doi.org\/10.1093\/annonc\/mdv037.","journal-title":"Ann Oncol"},{"issue":"1","key":"1110_CR14","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/1754-9485.12251","volume":"59","author":"C Acksteiner","year":"2015","unstructured":"Acksteiner C, Steinke K. Percutaneous microwave ablation for early-stage non-small cell lung cancer (NSCLC) in the elderly: a promising outlook: MWA for early-stage NSCLC in the elderly. J Med Imaging Radiat Oncol. 2015;59(1):82\u201390. https:\/\/doi.org\/10.1111\/1754-9485.12251.","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"6","key":"1110_CR15","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.jvir.2012.12.026","volume":"24","author":"H Yashiro","year":"2013","unstructured":"Yashiro H, Nakatsuka S, Inoue M, et al. Factors affecting local progression after Percutaneous Cryoablation of Lung Tumors. J Vasc Interv Radiol. 2013;24(6):813\u201321. https:\/\/doi.org\/10.1016\/j.jvir.2012.12.026.","journal-title":"J Vasc Interv Radiol"},{"issue":"8","key":"1110_CR16","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.crad.2017.01.005","volume":"72","author":"T de Baere","year":"2017","unstructured":"de Baere T, Tselikas L, Gravel G, et al. Lung ablation: best practice\/results\/response assessment\/role alongside other ablative therapies. Clin Radiol. 2017;72(8):657\u201364. https:\/\/doi.org\/10.1016\/j.crad.2017.01.005.","journal-title":"Clin Radiol"},{"issue":"04","key":"1110_CR17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1055\/s-0039-1697002","volume":"36","author":"PW Eiken","year":"2019","unstructured":"Eiken PW, Welch BT. Cryoablation of Lung Metastases: review of recent literature and ablation technique. Semin Interv Radiol. 2019;36(04):319\u201325. https:\/\/doi.org\/10.1055\/s-0039-1697002.","journal-title":"Semin Interv Radiol"},{"issue":"4","key":"1110_CR18","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/j.1464-410X.2011.10885.x","volume":"110","author":"R El Dib","year":"2012","unstructured":"El Dib R, Touma NJ, Kapoor A. Cryoablation vs radiofrequency ablation for the treatment of renal cell carcinoma: a meta-analysis of case series studies: CRYOABLATION VS RADIOFREQUENCY ABLATION IN RCC. BJU Int. 2012;110(4):510\u20136. https:\/\/doi.org\/10.1111\/j.1464-410X.2011.10885.x.","journal-title":"BJU Int"},{"issue":"3","key":"1110_CR19","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jvir.2014.12.006","volume":"26","author":"W Moore","year":"2015","unstructured":"Moore W, Talati R, Bhattacharji P, et al. Five-year survival after Cryoablation of Stage I non\u2013small cell Lung Cancer in medically inoperable patients. J Vasc Interv Radiol. 2015;26(3):312\u20139. https:\/\/doi.org\/10.1016\/j.jvir.2014.12.006.","journal-title":"J Vasc Interv Radiol"},{"issue":"3","key":"1110_CR20","doi-asserted-by":"publisher","first-page":"590","DOI":"10.21037\/jtd.2017.03.14","volume":"9","author":"L Zhong","year":"2017","unstructured":"Zhong L, Sun S, Shi J, et al. Clinical analysis on 113 patients with lung cancer treated by percutaneous CT-guided microwave ablation. J Thorac Dis. 2017;9(3):590\u20137. https:\/\/doi.org\/10.21037\/jtd.2017.03.14.","journal-title":"J Thorac Dis"},{"issue":"49","key":"1110_CR21","doi-asserted-by":"publisher","first-page":"e2252","DOI":"10.1097\/MD.0000000000002252","volume":"94","author":"S Wu","year":"2015","unstructured":"Wu S, Hou J, Ding Y, et al. Cryoablation Versus Radiofrequency ablation for hepatic malignancies: a systematic review and literature-based analysis. Med (Baltim). 2015;94(49):e2252. https:\/\/doi.org\/10.1097\/MD.0000000000002252.","journal-title":"Med (Baltim)"},{"issue":"3","key":"1110_CR22","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jvir.2011.11.019","volume":"23","author":"M Inoue","year":"2012","unstructured":"Inoue M, Nakatsuka S, Yashiro H, et al. Percutaneous cryoablation of lung tumors: feasibility and safety. J Vasc Interv Radiol. 2012;23(3):295\u2013302. https:\/\/doi.org\/10.1016\/j.jvir.2011.11.019.","journal-title":"J Vasc Interv Radiol"},{"issue":"5","key":"1110_CR23","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1002\/hep.27548","volume":"61","author":"C Wang","year":"2015","unstructured":"Wang C, Wang H, Yang W, et al. Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma: HEPATOLOGY, Vol.\u00a000, no. X, 2014. Hepatology. 2015;61(5):1579\u201390. https:\/\/doi.org\/10.1002\/hep.27548.","journal-title":"Hepatology"},{"issue":"8","key":"1110_CR24","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.jvir.2012.04.033","volume":"23","author":"N Ito","year":"2012","unstructured":"Ito N, Nakatsuka S, Inoue M, et al. Computed Tomographic Appearance of Lung Tumors treated with Percutaneous Cryoablation. J Vasc Interv Radiol. 2012;23(8):1043\u201352. https:\/\/doi.org\/10.1016\/j.jvir.2012.04.033.","journal-title":"J Vasc Interv Radiol"},{"issue":"10","key":"1110_CR25","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1097\/JTO.0000000000000632","volume":"10","author":"T de Baere","year":"2015","unstructured":"de Baere T, Tselikas L, Woodrum D, et al. Evaluating cryoablation of metastatic lung tumors in patients\u2014safety and efficacy the ECLIPSE Trial\u2014Interim analysis at 1 year. J Thorac Oncol. 2015;10(10):1468\u201374. https:\/\/doi.org\/10.1097\/JTO.0000000000000632.","journal-title":"J Thorac Oncol"},{"key":"1110_CR26","doi-asserted-by":"publisher","unstructured":"Leppelmann KS, Levesque VM, Bunck AC, et al. Outcomes following Percutaneous Microwave and Cryoablation of Lung Metastases from Adenoid cystic carcinoma of the Head and Neck: a bi-institutional retrospective cohort study. Ann Surg Oncol Published Online February. 2021;23. https:\/\/doi.org\/10.1245\/s10434-021-09714-4.","DOI":"10.1245\/s10434-021-09714-4"},{"issue":"7","key":"1110_CR27","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.jtho.2020.02.022","volume":"15","author":"MR Callstrom","year":"2020","unstructured":"Callstrom MR, Woodrum DA, Nichols FC, et al. Multicenter Study of metastatic lung tumors targeted by interventional cryoablation evaluation (SOLSTICE). J Thorac Oncol. 2020;15(7):1200\u20139. https:\/\/doi.org\/10.1016\/j.jtho.2020.02.022.","journal-title":"J Thorac Oncol"},{"key":"1110_CR28","doi-asserted-by":"publisher","unstructured":"de Ba\u00e8re T, Woodrum D, Tselikas L, et al. The ECLIPSE Study: efficacy of Cryoablation on metastatic lung tumors with a 5-Year Follow-Up. J Thorac Oncol Published Online August. 2021;9. https:\/\/doi.org\/10.1016\/j.jtho.2021.07.021.","DOI":"10.1016\/j.jtho.2021.07.021"},{"issue":"2","key":"1110_CR29","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1177\/08465371221122807","volume":"74","author":"ET Nguyen","year":"2023","unstructured":"Nguyen ET, Bayanati H, Hurrell C, et al. Canadian Association of Cadiologists \/ Canadian Association for Interventional Radiology\/ Canadian Society of thoracic Radiology Guidelines on thoracic interventions. Can Assoc Radiol J. 2023;74(2):272\u201387. https:\/\/doi.org\/10.1177\/08465371221122807.","journal-title":"Can Assoc Radiol J"},{"issue":"1","key":"1110_CR30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1159\/000502744","volume":"9","author":"M Maeda","year":"2020","unstructured":"Maeda M, Saeki I, Sakaida I, et al. Complications after Radiofrequency ablation for Hepatocellular Carcinoma: a Multicenter Study Involving 9,411 japanese patients. Liver Cancer. 2020;9(1):50\u201362. https:\/\/doi.org\/10.1159\/000502744.","journal-title":"Liver Cancer"},{"issue":"1","key":"1110_CR31","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2214\/AJR.18.19527","volume":"212","author":"GR Lyons","year":"2019","unstructured":"Lyons GR, Winokur RS, Pua BB. Pulmonary cryoablation zones: more aggressive ablation is warranted in vivo. Am J Roentgenol. 2019;212(1):195\u2013200. https:\/\/doi.org\/10.2214\/AJR.18.19527.","journal-title":"Am J Roentgenol"},{"key":"1110_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2214\/AJR.21.25872","volume":"22","author":"MM Wrobel","year":"2021","unstructured":"Wrobel MM, Bourgouin PP, Kashani MA, et al. Active Versus Passive Thaw after Percutaneous Cryoablation of Pulmonary Tumors: Effect on Incidence, Grade, and Onset of Hemoptysis. Am J Roentgenol Published Online September. 2021;22:1\u201311. https:\/\/doi.org\/10.2214\/AJR.21.25872.","journal-title":"Am J Roentgenol Published Online September"},{"issue":"4","key":"1110_CR33","doi-asserted-by":"publisher","first-page":"316","DOI":"10.5152\/dir.2014.13440","volume":"20","author":"E Colak","year":"2014","unstructured":"Colak E, Tatli S, Shyn PB, Tuncali K, Silverman SG. CT-guided percutaneous cryoablation of central lung tumors. Diagn Interv Radiol. 2014;20(4):316\u201322. https:\/\/doi.org\/10.5152\/dir.2014.13440.","journal-title":"Diagn Interv Radiol"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-023-01110-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-023-01110-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-023-01110-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T00:08:55Z","timestamp":1700611735000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-023-01110-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,9]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1110"],"URL":"https:\/\/doi.org\/10.1186\/s12880-023-01110-6","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,9]]},"assertion":[{"value":"15 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We confirmed this study was carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We hereby confirm that all experimental protocols were approved by a named institutional and\/or licensing committee. (IRB of Cathay General Hospital )","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We confirmed the IRB of Cathay General Hospital waived the need for informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"151"}}